Plasma disposition and tissue residue of Moxifloxacin in Japanese quails (Coturnix japonica) following different routes of administration

REFERENCES

• Aboubakr, M. (2012) Pharmacokinetics of levofloxacin in Japanese quails (Coturnix japonica) following intravenous and oral administration. British Poultry Science, 53: 784–789. doi:10.1080/00071668.2012.745928
   PubMed Web of Science ®Google Scholar
• Anadón, A., Suárez, F.H., Martínez, M.A., Castellano, V., Martínez, M., Ares, I., Ramos, E., Gamboa, F. & Martínez-Larrañaga, M.R. (2011) Plasma disposition and tissue depletion of difloxacin and its metabolite sarafloxacin in the food producing animals, chickens for fattening. Food and Chemical Toxicology, 49: 441–449. doi:10.1016/j.fct.2010.11.021
   PubMed Web of Science ®Google Scholar
• Cárceles, C.M., Serrano, J.M., Marin, P., Escudero, E. & Fernández-Varón, E. (2006) Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer 407 gel formulation administration. Journal of Veterinary Medicine Series A, 53: 300–304. doi:10.1111/j.1439-0442.2006.00827.x
   PubMedGoogle Scholar
• Dalhoff, A., Petersen, U. & Endermann, R. (1996) In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy, 42: 410–425. doi:10.1159/000239474
   PubMed Web of Science ®Google Scholar
• Dimitrova, D., Moutafchieva, R., Kanelov, I., Dinev, T., Yanev, S., Pandova, B. & Lashev, L. (2008) Pharmacokinetics of pefloxacin and its metabolite norfloxacin in male and female ducks. Journal of Veterinary Pharmacology and Therapeutics, 31: 167–170. doi:10.1111/j.1365-2885.2007.00928.x
   PubMed Web of Science ®Google Scholar
• Fernández-Varón, E., Bovaira, M.J., Espuny, A., Escudero, E., Vancraeynest, D. & Cárceles, C.M. (2005) Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. Journal of Veterinary Pharmacology and Therapeutics, 28: 343–348. doi:10.1111/j.1365-2885.2005.00665.x
   PubMed Web of Science ®Google Scholar
• Fernández-Varón, E., Marin, P., Escudero, E., Vancraeynest, D. & Cárceles, C.M. (2007) Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits. Journal of Veterinary Pharmacology and Therapeutics, 30: 18–24. doi:10.1111/j.1365-2885.2007.00807.x
   PubMed Web of Science ®Google Scholar
• Gibaldi, M. & Perrier, D. (1982) Non Compartmental Analysis Based on Statistical Moment Theory. Pharmacokinetics, 2nd edn, pp. 409–417 (New York, Marcel Dekker).
   Google Scholar
• Goudah, A. (2009) Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens. British Poultry Science, 50: 251–258. doi:10.1080/00071660802710108
   PubMed Web of Science ®Google Scholar
• Goudah, A. & Hasabelnaby, S. (2010) Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration. Research in Veterinary Science, 88: 507–511. doi:10.1016/j.rvsc.2009.11.009
   PubMed Web of Science ®Google Scholar
• Haritova, A.M., Rusenova, N.V., Parvanov, P.R., Lashev, L.D. & Fink-Gremmels, J. (2006) Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys. Antimicrobial Agents and Chemotherapy, 50: 3779–3785. doi:10.1128/AAC.00711-05
   PubMed Web of Science ®Google Scholar
• Intorre, L., Mengozzi, G., Bertini, S., Bagliacca, M., Luchetti, E. & Soldani, G. (1997) The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck. Veterinary Research Communications, 21: 127–136. doi:10.1023/A:1005773603905
   PubMed Web of Science ®Google Scholar
• Knoll, U., Glunder, G. & Kietzmann, M. (1999) Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens. Journal of Veterinary Pharmacology and Therapeutics, 22: 239–246. doi:10.1046/j.1365-2885.1999.00217.x
   PubMed Web of Science ®Google Scholar
• Kowalski, R.P., Dhaliwal, D.K., Karenchak, L.M., Romanowski, E.G., Mah, F.S., Ritterband, D.C. & Gordon, Y.J. (2003) Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. American Journal of Ophthalmology, 136: 500–505. doi:10.1016/S0002-9394(03)00294-0
   PubMed Web of Science ®Google Scholar
• Levy, S.B. (2002) The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. Journal of Antimicrobial Chemotherapy, 49: 25–30. doi:10.1093/jac/49.1.25
   PubMed Web of Science ®Google Scholar
• Mohan, J., Sastry, K.V., Tyagi, J.S., Rao, G.S. & Singh, R.V. (2006) Residues of fluoroquinolone drugs in the cloacal gland and other tissues of Japanese quail. British Poultry Science, 47: 83–87. doi:10.1080/00071660500468173
   PubMed Web of Science ®Google Scholar
• Nix, D.E., Goodwin, S.D., Peloquin, C.A., Rotella, D.L. & Schentag, J.J. (1991) Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrobial Agents and Chemotherapy, 35: 1953–1959. doi:10.1128/AAC.35.10.1953
   PubMed Web of Science ®Google Scholar
• Pant, S., Rao, G.S., Sastry, K.V., Tripathi, H.C., Jagmohan, & Malik, J.K. (2005) Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens. British Poultry Science, 46: 615–620. doi:10.1080/00071660500255323
   PubMed Web of Science ®Google Scholar
• Riviere, J.E. & Papich, M.G. (2009) Veterinary Pharmacology and Therapeutics, pp. xvi, 1524 p (Ames, IA, Wiley-Blackwell).
   Google Scholar
• Toutain, P.L. & Bousquet-Mélou, A. (2004) Volumes of distribution. Journal of Veterinary Pharmacology and Therapeutics, 27: 441–453. doi:10.1111/j.1365-2885.2004.00602.x
   PubMed Web of Science ®Google Scholar
• Toutain, P.L., Del Castillo, J.R.E. & Bousquet-Mélou, A. (2002) The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science, 73: 105–114. doi:10.1016/S0034-5288(02)00039-5
   PubMed Web of Science ®Google Scholar
• Toutain, P.L. & Lees, P. (2004) Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27: 467–477. doi:10.1111/j.1365-2885.2004.00613.x
   PubMed Web of Science ®Google Scholar
• Turnidge, J. (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs, 58 (Suppl 2): 29–36. doi:10.2165/00003495-199958002-00006
   PubMed Web of Science ®Google Scholar
• Van Bambeke, F., Michot, J.M., Van Eldere, J. & Tulkens, P.M. (2005) Quinolones in 2005: an update. Clinical Infectious Diseases, 11: 256–280.
   Google Scholar
• Wolfson, J.S. & Hooper, D.C. (1985) The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy, 28: 581–586. doi:10.1128/AAC.28.4.581
   PubMed Web of Science ®Google Scholar
• Woodcock, J.M., Andrews, J.M., Boswell, F.J., Brenwald, N.P. & Wise, R. (1997) In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy, 41: 101–106.
   PubMed Web of Science ®Google Scholar
• Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6: 547–558. doi:10.1007/BF01062109
   PubMedGoogle Scholar